exRNAdisease

Entry Detail

---



General Information

Database ID: exR0268922 RNA Name: hsa-miR-15b-5p RNA Type: miRNA Chromosome: chr3 Starnd: + Coordinate: Start Site(bp): 160404607 End Site(bp): 160404628 External Links: hsa-miR-15b-5p

Disease Information

Disease Name: Chronic Thromboembolic Pulmonary Hypertension Disease Category: Respiratory Tract Diseases MeSH ID: D006976 Type: Diseases Category/Respiratory Tract Diseases Alias: Hypertension, Pulmonary//Pulmonary Hypertension

Expression Detail

GEO ID: GSE138107 Description: Non-invasive approach for evaluation of CTEPH using extracellular vesicle-associated small non-coding RNA Experimental Design: Disease vs Control Case Disease Type: Chronic Thromboembolic Pulmonary Hypertension Case Disease SubType: NA Case Sample: Chronic Thromboembolic Pulmonary Hypertension Control Sample: Control Number of Case: 3 Number of Control: 3 Number of Samples: 6

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand URM1 chr9 128371361 128392016 + STEAP3 chr2 119223831 119265652 + ABCF3 chr3 184186023 184194012 + RAB11FIP1 chr8 37858618 37899497 - FAM89A chr1 231018958 231040254 - LITAF chr16 11547722 11636381 - ZBTB34 chr9 126860665 126885878 + LY6E chr8 143017982 143023832 + ATG14 chr14 55366391 55411830 - MINDY2 chr15 58771192 58861900 + MRPS2 chr9 135499984 135504673 + DCAF7 chr17 63550477 63594279 + ANKRD17 chr4 73073376 73258798 - JARID2 chr6 15246069 15522042 + RAPGEF1 chr9 131576770 131740074 - MLEC chr12 120687149 120701859 + FAM102B chr1 108560089 108644900 + ARRDC4 chr15 97960703 97973833 + ERG28 chr14 75649791 75660876 - CRY2 chr11 45847118 45883248 + TSPYL2 chrX 53082367 53088540 + E2F3 chr6 20401879 20493714 + ABHD2 chr15 89087459 89202355 + PIK3R1 chr5 68215756 68301821 + MED11 chr17 4731428 4733607 + SCAMP4 chr19 1905372 1926013 + SRPK1 chr6 35832966 35921342 - FLOT2 chr17 28879335 28897733 - MYB chr6 135181308 135219173 + HDGF chr1 156742109 156766925 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000540 chr14 55799534 55821940 + hsa_circ_0001005 chr2 53921020 53978078 - hsa_circ_0001723 chr7 91924202 91948826 + hsa_circ_0000458 chr12 124071293 124074996 + hsa_circ_0001699 chr7 40027197 40041630 + hsa_circ_0001387 chr4 1902352 1936989 + hsa_circ_0001168 chr20 47691321 47707559 + hsa_circ_0000552 chr14 71880664 71948928 + hsa_circ_0000038 chr1 28800065 28802803 + hsa_circ_0000652 chr15 90984737 90986710 + hsa_circ_0001472 chr5 36953719 36976504 + hsa_circ_0001263 chr3 5215701 5216099 + hsa_circ_0000799 chr17 65941524 65972074 + hsa_circ_0001164 chr20 45891031 45923523 - hsa_circ_0000032 chr1 25666964 25669564 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand LINC00649 chr21 33915534 33977691 + AL031282.2 chr1 1702736 1737688 - MZF1-AS1 chr19 58559129 58574797 + SNHG16 chr17 76557764 76565348 + XIST chrX 73820649 73852723 - STAG3L5P-PVRIG2P-PILRB chr7 100336104 100367831 + NUTM2B-AS1 chr10 79661394 79826594 - MCM3AP-AS1 chr21 46229196 46259390 + AL391244.1 chr1 1420245 1422691 + AC003092.1 chr7 94022833 94066661 + AC114980.1 chr5 93860669 93863825 - AC079781.5 chr7 97851688 97972985 - AC021092.1 chr19 44103007 44113183 - AC009022.1 chr16 69976297 70065948 - AL359924.1 chr1 237862175 237928321 + FGD5-AS1 chr3 14920347 14948424 - MIR497HG chr17 7015818 7019659 - AC021078.1 chr5 149494314 149504670 - LINC01184 chr5 127939152 128083172 - NEAT1 chr11 65422774 65445540 + SNHG1 chr11 62851984 62855953 - AC002470.2 chr22 20979462 20998121 + MIR29B2CHG chr1 207801518 207879115 - LINC00662 chr19 27681072 27794005 - MIR503HG chrX 134543119 134546642 - SNHG25 chr17 64145970 64146476 + LINC02035 chr3 122886941 122892416 + NUTM2A-AS1 chr10 87201647 87342612 - HCG18 chr6 30286690 30327382 - SNHG12 chr1 28578538 28583132 - Display:

Experiment Detail

GEO ID: GSE138107 Sample Source: Blood Source Fraction: Exosome Platform: GPL18573 Method: NGS Num of detected RNA Type: 3 Num of detected RNAs of this Type: 359 Sample treatment protocol: Serum was collected by centrifugation at 3000×g for 10 min and samples were then frozen at -80°C until analysis. RNA Extract protocol: total RNA RNA was isolated using the ExoRNeasy Midi kit (Qiagen, Hilden, Germany) with a starting volume of 100 ul serum. RNA library preparation protocol: SncRNA libraries were prepared using the TrueQuant technology (GenXPro, Frankfurt am Main, Germany)

Reference

PMID: 31671920 Title: Non-Invasive Approach for Evaluation of Pulmonary Hypertension Using Extracellular Vesicle-Associated Small Non-Coding RNA Author: Lipps C, Northe P, Figueiredo R, Rohde M, Brahmer A, Kr?mer-Albers EM, Liebetrau C, Wiedenroth CB, Mayer E, Kriechbaum SD, D?rr O, Nef H, Hamm CW, Keller T, Troidl C Journal: Biomolecules. 2019 Oct 29;9(11). pii: E666. Description: We aimed to determine whether extracellular vesicles isolated from patients with pulmonary hypertension show a disease specific signature of small non-coding RNAs and thus have the potential to serve as diagnostic and prognostic biomarkers.